Please Wait...

IGF-1 // Insulin-Like Growth Factor I or Somatomedin C

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Insulin Like Growth Factor 1 (IGF-1) and 2 (IGF-2) are produced mainly by hepatocytes, and to a lesser extent in other tissues (Ranke, 2015). IGF-1 and IGF-2 have structural and sequence homology with insulin and also shared some biological functions. These hormone were assigned in 1978 to the family of somatomedins (Rinderknecht and Humbel, 1978a, 1978b). Higher risks of cancer were found to be associated with high IGF-1 levels in serum. This can be the result of IGF-1 influence on epithelial-cell population renewal rates and of its anti-apoptotic effect (Pollak et al., 2004). IGF-1 circulates as a ternary complex with Acid Labile Subunit (ALS) and IGF-Binding Proteins (IGFBPs) and less than 1% is free. As a direct mediator, non-affected by diurnal fluctuation, serum IGF-1 reflect the levels of Growth Hormone (GH) and is used in the diagnosis of a wide range of diseases arising from GH deficiency or excess (Ketha and Singh, 2015).

Bioclinica Lab employs a manual sandwich radioimmunoassay for measurement of IGF-1 in serum.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Join Bioclinica in a live #Xtalks webinar 10/31 exploring challenges & benefits of different sourcing models to man…
bioclinica (2 hours ago)
Bioclinica contributions toward advancement of #Alzheimer's disease research & therapies showcased in 8 different s…
bioclinica (8 hours ago)
Bioclinica’s Joby John reflects on the #SCDM2018 Annual Conference & being a part a thriving community of clinical…
bioclinica (Yesterday)
RT @bioclinica: Our own Jeff Heilbraun is in Tokyo nxt wk to lead a discussion at DIA’s Cardiac Safety Workshop in Japan. Jeff will give an…
bioclinica (Yesterday)
RT @Xtalks: Trends in #SitePayments: Insight into How CROs Can Gain a Competitive Edge This webinar will focus on the latest market researc…
bioclinica (Yesterday)
Great connecting w @bioclinica clients Odonate Therapeutics, Eisai, & PCI Biotech, at #ESMO18 #oncology…
bioclinica (Yesterday)

Latest Blogs:

Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner